CHST3 and colorectal carcinoma: Emerging evidence from in vivo, in vitro, and nanotechnology-based studies highlights the potential of HSD and HST to modulate important molecular pathways involved in CRC pathogenesis, like inflammatory responses, oxidative stress, apoptosis, and cell cycle regulation (13–15).